Showing results (21-30 of 269) with videos related to
Sort By:
Pageof 27
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2002
Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonismAndrew Feigin, Angelo Antonini, Masafumi Fukuda, et al.Annals of Neurology|November 2, 2005
Preclinical Huntington's disease: compensatory brain responses during learningAndrew Feigin, Maria-Felice Ghilardi, Chaorui Huang, et al.Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Evidence from biomarkers and surrogate endpointsAndrew FeiginBrain and Language|August 11, 2006
The assessment of neurological systems with functional imagingDavid EidelbergTrends in Neurosciences|September 22, 2009
Metabolic brain networks in neurodegenerative disorders: a functional imaging approachDavid EidelbergThe Journal of Clinical Investigation|July 19, 2014
Network modulation following sham surgery in Parkinson's diseaseJi Hyun Ko, Andrew Feigin, Paul J Mattis, et al.The Lancet. Neurology|January 12, 2010
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysisChris C Tang, Kathleen L Poston, Thomas Eckert, et al.Expert Opinion on Emerging Drugs|July 28, 2021
Emerging therapeutics in Huntington's diseaseRobert Wiggins, Andrew FeiginNeurodegenerative Disease Management|December 18, 2012
Monitoring Huntington's disease progression through preclinical and early stagesChris Tang, Andrew FeiginCurrent Opinion in Neurology|August 2, 2002
Recent advances in Huntington's disease: implications for experimental therapeuticsAndrew Feigin, Dennis ZgaljardicPageof 27